EMAS Position Statement | The role of vitamin D in menopausal health

EMAS is extremely proud to announce the publication of a new position statement on The role of vitamin D in menopausal health
The widespread tissue effects of vitamin D, along with the high prevalence of vitamin D deficiency worldwide, have led to the injudicious use of vitamin D supplements. Except for its well-established role in bone metabolism, vitamin D deficiency has been associated with a plethora of non-skeletal diseases, such as cardiovascular disease (CVD), diabetes, cancer and infections. However, the effect of vitamin D supplementation on these outcomes requires clarification, especially in postmenopausal women, since heterogeneity exists among studies in terms of baseline vitamin D status, dosage, calcium co-administration, and duration of intervention.
This position statement from the European Menopause and Andropause Society (EMAS) aims to provide an evidence-based approach focusing on the role of vitamin D in postmenopausal women based on observational studies and interventional randomized controlled trials.